Jung Yoon Pyo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jung Yoon Pyo has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Sang-Won Lee
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
21 shared publications - Yong-Beom Park
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
18 shared publications - Jason Jungsik Song
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
17 shared publications - Sung Soo Ahn
Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Gyeonggi-do, Republic of Korea
14 shared publications - Lucy Eunju Lee
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
5 shared publications - Taejun Yoon
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by The Korean Society of Sex-and Gender-Specific Biomedical Science in Sex- and Gender-Specific Biomedicine
- Vol. 1 (3) , 278-287
Sex Differences in Clinical Manifestations and Early Flare Outcomes in Korean Patients with Systemic Lupus Erythematosus: A Prospective Single-Center Cohort Study
You-Jung Ha, Jung Yoon Pyo, Se Rim Choi, Eun Ha Kang, Yun Jong Lee. Sex Gender Biomed 2026;1:278-87. https://doi.org/10.65400/SGBM.2026.1.3.278
- 30 September 2026
- Published by The Korean Society of Sex-and Gender-Specific Biomedical Science in Sex- and Gender-Specific Biomedicine
- Vol. 1 (3) , 278-287
Open AccessSex Differences in Clinical Manifestations and Early Flare Outcomes in Korean Patients with Systemic Lupus Erythematosus: A Prospective Single-Center Cohort Study
You-Jung Ha, Jung Yoon Pyo, Se Rim Choi, Eun Ha Kang, Yun Jong Lee. Sex Gender Biomed 2026;1:278-87. https://doi.org/10.65400/SGBM.2026.1.3.278
- Open Access
- 28 July 2025
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting with relapsing polychondritis-like features in a patient with thymoma: a case report
Jung Yoon Pyo, M.D., Sang Mee Hwang, M.D., Ph.D., Sang-A Kim, M.D., You-Jung Ha, M.D., Ph.D., Eun Ha Kang, M.D., Ph.D., M.P.H., Yun Jong Lee, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2025.0072
- 28 July 2025
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
Open AccessVacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting with relapsing polychondritis-like features in a patient with thymoma: a case report
Jung Yoon Pyo, M.D., Sang Mee Hwang, M.D., Ph.D., Sang-A Kim, M.D., You-Jung Ha, M.D., Ph.D., Eun Ha Kang, M.D., Ph.D., M.P.H., Yun Jong Lee, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2025.0072
- Open Access
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (12) , 833-840
Initial Circulating CD138 Predicts End-Stage Kidney Disease in Patients with Microscopic Polyangiitis
Pyo JY, et al. Yonsei Med J. 2025 Sep;66:e90. https://doi.org/10.3349/ymj.2024.0457
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (12) , 833-840
Open AccessInitial Circulating CD138 Predicts End-Stage Kidney Disease in Patients with Microscopic Polyangiitis
Pyo JY, et al. Yonsei Med J. 2025 Sep;66:e90. https://doi.org/10.3349/ymj.2024.0457
- 11 November 2023
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 34 (5) , 1006-1012
Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria
Objectives: Recently, a joint group of the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) proposed new criteria for Takayasu arteritis (TAK) (the 2022 ACR/EULAR criteria). This study applied the 2022 ACR/EULAR criteria to patients with previously diagnosed TAK based on the 1990 ACR criteria and investigated the concordance rate between the two criteria according to the four imaging modalities. Methods: This study reviewed the medical records of 179 patients who met the 1990 ACR criteria for TAK. The imaging modalities included conventional angiography, computed tomography angiography, fluorodeoxyglucose-positron emission tomography, and magnetic resonance angiography. Results: Regardless of the imaging modalities, the concordance rate between the two criteria was 85.5% when including all patients, whereas it increased to 98.1% when only patients aged ≤60 years were included. Among the four imaging modalities, computed tomography angiography exhibited the highest concordance rate between the two criteria (85.6%). The concordance rate among patients aged >60 years was 95.7%. Only one patient aged 50–60 years was reclassified as having both TAK and giant cell arteritis. Conclusions: The concordance rate was 85.5% regardless of the imaging modalities and increased to 86.9% on simultaneous computed tomography angiography and fluorodeoxyglucose-positron emission tomography imaging.
- 11 November 2023
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 34 (5) , 1006-1012
Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria
Objectives: Recently, a joint group of the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) proposed new criteria for Takayasu arteritis (TAK) (the 2022 ACR/EULAR criteria). This study applied the 2022 ACR/EULAR criteria to patients with previously diagnosed TAK based on the 1990 ACR criteria and investigated the concordance rate between the two criteria according to the four imaging modalities. Methods: This study reviewed the medical records of 179 patients who met the 1990 ACR criteria for TAK. The imaging modalities included conventional angiography, computed tomography angiography, fluorodeoxyglucose-positron emission tomography, and magnetic resonance angiography. Results: Regardless of the imaging modalities, the concordance rate between the two criteria was 85.5% when including all patients, whereas it increased to 98.1% when only patients aged ≤60 years were included. Among the four imaging modalities, computed tomography angiography exhibited the highest concordance rate between the two criteria (85.6%). The concordance rate among patients aged >60 years was 95.7%. Only one patient aged 50–60 years was reclassified as having both TAK and giant cell arteritis. Conclusions: The concordance rate was 85.5% regardless of the imaging modalities and increased to 86.9% on simultaneous computed tomography angiography and fluorodeoxyglucose-positron emission tomography imaging.
- 2 February 2023
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 83 (S1) , 230-235
Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis
Objective This study investigated whether circulating cold-inducible RNA-binding protein (CIRP) could be a biomarker to reflect the current activity, function, and damage status in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Methods This study selected 39 MPA and 26 GPA patients. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)-specific indices include the Birmingham Vasculitis Activity Index (BVAS), five-factor score (FFS), the Korean version of the Short-Form 36-Item Health Survey (SF-36) physical component summary (PCS) and mental component summary (MCS), and the vasculitis damage index (VDI). The highest tertile of BVAS was defined as high activity of AAV. Results The median age of the study subjects was 65.0 years and 53.8% were women. The median BVAS, FFS, SF-36 PCS, MCS, and VDI scores were 12.0, 2.0, 47.5, 50.3, and 3.0, respectively. The median circulating CIRP level was 6.4 ng/mL. Among the four AAV-specific indices, circulating CIRP was significantly correlated with BVAS (r = 0.256). Using the receiver operator characteristic curve, the cut-off of circulating CIRP for high activity of AAV was 6.16 ng/mL. High activity of AAV was identified more frequently in patients with circulating CIRP ≥ 6.16 ng/mL than in those with circulating CIRP < 6.16 ng/mL (48.6% vs. 21.4%). In addition, patients with circulating CIRP ≥ 6.16 ng/mL exhibited a significantly higher risk for high activity of AAV than those with circulating CIRP < 6.16 ng/mL (relative risk 3.474). Conclusion This study suggests the clinical potential of circulating CIRP as a biomarker for reflecting the current BVAS and predicting high activity of AAV in patients with MPA and GPA.
- 2 February 2023
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 83 (S1) , 230-235
Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis
Objective This study investigated whether circulating cold-inducible RNA-binding protein (CIRP) could be a biomarker to reflect the current activity, function, and damage status in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Methods This study selected 39 MPA and 26 GPA patients. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)-specific indices include the Birmingham Vasculitis Activity Index (BVAS), five-factor score (FFS), the Korean version of the Short-Form 36-Item Health Survey (SF-36) physical component summary (PCS) and mental component summary (MCS), and the vasculitis damage index (VDI). The highest tertile of BVAS was defined as high activity of AAV. Results The median age of the study subjects was 65.0 years and 53.8% were women. The median BVAS, FFS, SF-36 PCS, MCS, and VDI scores were 12.0, 2.0, 47.5, 50.3, and 3.0, respectively. The median circulating CIRP level was 6.4 ng/mL. Among the four AAV-specific indices, circulating CIRP was significantly correlated with BVAS (r = 0.256). Using the receiver operator characteristic curve, the cut-off of circulating CIRP for high activity of AAV was 6.16 ng/mL. High activity of AAV was identified more frequently in patients with circulating CIRP ≥ 6.16 ng/mL than in those with circulating CIRP < 6.16 ng/mL (48.6% vs. 21.4%). In addition, patients with circulating CIRP ≥ 6.16 ng/mL exhibited a significantly higher risk for high activity of AAV than those with circulating CIRP < 6.16 ng/mL (relative risk 3.474). Conclusion This study suggests the clinical potential of circulating CIRP as a biomarker for reflecting the current BVAS and predicting high activity of AAV in patients with MPA and GPA.
- Top Cited PapersOpen Access
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (1) , 11-17
Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
Pyo JY, et al. Yonsei Med J. 2023 Jan;64(1):11-17. https://doi.org/10.3349/ymj.2022.0435
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (1) , 11-17
Top Cited PapersOpen AccessComparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
Pyo JY, et al. Yonsei Med J. 2023 Jan;64(1):11-17. https://doi.org/10.3349/ymj.2022.0435
- Open Access
- 30 December 2022
- Published by The Korean Academy of Geriatrics & Gerontology in Korean Journal of Geriatrics & Gerontology
- Vol. 23 (2) , 96-114
Acute Ischemic Stroke in the Patients with Inflammatory Arthritis: An Analysis of Data from National Health Insurance Service
- 30 December 2022
- Published by The Korean Academy of Geriatrics & Gerontology in Korean Journal of Geriatrics & Gerontology
- Vol. 23 (2) , 96-114
Open AccessAcute Ischemic Stroke in the Patients with Inflammatory Arthritis: An Analysis of Data from National Health Insurance Service
- Open Access
- 6 December 2022
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 30 (1) , 45-52
Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center
Hyunsue Do, M.D., Jung Yoon Pyo, M.D., Jason Jungsik Song, M.D., Ph.D., Yong-Beom Park M.D., Ph.D., Sang-Won Lee, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.22.0033
- 6 December 2022
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 30 (1) , 45-52
Open AccessImplication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center
Hyunsue Do, M.D., Jung Yoon Pyo, M.D., Jason Jungsik Song, M.D., Ph.D., Yong-Beom Park M.D., Ph.D., Sang-Won Lee, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.22.0033
- 15 September 2022
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 50 (2) , 213-218
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Objective: The American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) have proposed the 2022 classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA). This study applied the 2022 ACR/EULAR criteria to Korean patients with previously diagnosed EGPA to investigate the concordance rate between the 2022 ACR/EULAR criteria and the old criteria for EGPA.Methods: In total, 51 patients with EGPA who met the 1990 ACR criteria, the 2007 European Medicines Agency algorithm, and the 2012 Chapel Hill Consensus Conference definitions were reclassified based on the 2022 ACR/EULAR criteria.Results: Of 51 patients, 44 (86.3%) were reclassified as having EGPA according to the 2022 ACR/EULAR criteria. Among the 7 patients who failed to meet the 2022 ACR/EULAR criteria, 3 patients were reclassified as having microscopic polyangiitis (MPA) and 1 was reclassified as having granulomatosis with polyangiitis (GPA) based on the 2022 ACR/EULAR criteria; as well, 3 patients were reclassified as having unclassifiable vasculitis. Moreover, 6 patients who met the 2022 ACR/EULAR criteria for EGPA simultaneously met the criteria for MPA based on the 2022 ACR/EULAR criteria for MPA, and 1 who met the criteria for EGPA simultaneously met the criteria for GPA based on the 2022 ACR/EULAR criteria for GPA.Conclusion: The concordance rate between the 2022 ACR/EULAR criteria for EGPA and the old criteria was 86.3%. The most important factor in the failure to reclassify patients as having EGPA was the exclusion of nonfixed pulmonary infiltrates in the 1990 ACR criteria for EGPA. We cautiously suggest reconsidering nonfixed pulmonary infiltrates in cases reclassified as unclassifiable vasculitis. Further, additional classification strategies are needed for patients who simultaneously satisfy both antineutrophil cytoplasmic antibody–associated vasculitis subtypes.
- 15 September 2022
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 50 (2) , 213-218
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Objective: The American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) have proposed the 2022 classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA). This study applied the 2022 ACR/EULAR criteria to Korean patients with previously diagnosed EGPA to investigate the concordance rate between the 2022 ACR/EULAR criteria and the old criteria for EGPA.Methods: In total, 51 patients with EGPA who met the 1990 ACR criteria, the 2007 European Medicines Agency algorithm, and the 2012 Chapel Hill Consensus Conference definitions were reclassified based on the 2022 ACR/EULAR criteria.Results: Of 51 patients, 44 (86.3%) were reclassified as having EGPA according to the 2022 ACR/EULAR criteria. Among the 7 patients who failed to meet the 2022 ACR/EULAR criteria, 3 patients were reclassified as having microscopic polyangiitis (MPA) and 1 was reclassified as having granulomatosis with polyangiitis (GPA) based on the 2022 ACR/EULAR criteria; as well, 3 patients were reclassified as having unclassifiable vasculitis. Moreover, 6 patients who met the 2022 ACR/EULAR criteria for EGPA simultaneously met the criteria for MPA based on the 2022 ACR/EULAR criteria for MPA, and 1 who met the criteria for EGPA simultaneously met the criteria for GPA based on the 2022 ACR/EULAR criteria for GPA.Conclusion: The concordance rate between the 2022 ACR/EULAR criteria for EGPA and the old criteria was 86.3%. The most important factor in the failure to reclassify patients as having EGPA was the exclusion of nonfixed pulmonary infiltrates in the 1990 ACR criteria for EGPA. We cautiously suggest reconsidering nonfixed pulmonary infiltrates in cases reclassified as unclassifiable vasculitis. Further, additional classification strategies are needed for patients who simultaneously satisfy both antineutrophil cytoplasmic antibody–associated vasculitis subtypes.
- Open Access
- 1 July 2022
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 29 (3) , 154-161
Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Jung Yoon Pyo, M.D., Sung Soo Ahn, M.D., Ph.D., Jason Jungsik Song, M.D., Ph.D., Yong-Beom Park, M.D., Ph.D., Sang-Won Lee, M.D., Ph.D.. J Rheum Dis 2022;29:154-61. https://doi.org/10.4078/jrd.2022.29.3.154
- 1 July 2022
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 29 (3) , 154-161
Open AccessModified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Jung Yoon Pyo, M.D., Sung Soo Ahn, M.D., Ph.D., Jason Jungsik Song, M.D., Ph.D., Yong-Beom Park, M.D., Ph.D., Sang-Won Lee, M.D., Ph.D.. J Rheum Dis 2022;29:154-61. https://doi.org/10.4078/jrd.2022.29.3.154